Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06721468 · ClinicalTrials.gov registry record · NA

Trout Consumption in Young Children and Families and Brain Health

A NA study of Cognitive Change and Well-Being, Psychological, sponsored by University of Idaho.

Recruiting
Registry status
NA
Development phase
99
Enrollment target
2
Study locations

NCT06721468: Recruiting NA study of Cognitive Change and Well-Being, Psychological, sponsored by University of Idaho.

NCT06721468 is a NA study of Cognitive Change and Well-Being, Psychological that is actively recruiting participants, run by University of Idaho. The registered enrollment target is 99 participants, below the 178-participant average among 44 other Cognitive Change trials with a reported enrollment target (44% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06721468, a NA study of Cognitive Change and Well-Being, Psychological, is actively recruiting participants, sponsored by University of Idaho.

RECRUITING
Registry status
NA
Development phase
99 participants
Enrollment target
2
Study locations

Study Summary

Regular fish consumption may support brain health. Trout lines developed in Idaho contain higher levels of omega-3 fatty acids, nutrients important for human cognition and mental wellbeing. Developed to support aquaculture sustainability, consumer preferences and human health benefits of these fish are unknown. The long-term goal of this project is to utilize nutrition education strategies to increase adult and child consumption of fish to improve brain health as measured by cognitive and emotional wellbeing. Research objectives and activities include, (1) adult and child consumer panels to provide sensory evaluation on three strains of trout, (2) effects of repeated exposure (RE) and child-centered nutrition phrases (CCNP) on eating behaviors and brain health will be determined using one control and two treatment groups of children in childcare settings, (3) effects of nutrition education, incorporating CCNP and fish preparation techniques, and RE targeting family meals on eating behaviors of children and brain health of adults and children will be determined using four treatment groups in the home setting.

Primary Outcome

subjects rate their liking of trout on a 3-point scale (yummy, just okay, yucky)

Interventions

  • OTHER Trout
  • OTHER Child-centered nutrition phrases
  • OTHER Puzzle

Study Locations (2)

Idaho

  • University of Idaho - Moscow

Washington

  • Washington State University - Pullman

Trial Details

FieldValue
Enrollment Target 99 participants
Start Date 2024-05-13
Est. Completion 2027-12-31
Phase NA
University of Idaho

14 total trials

What NCT06721468 shows while recruiting

NCT06721468 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 178-participant average among 44 other Cognitive Change trials with a reported enrollment target (44% lower).

The record links to 2 conditions, with Cognitive Change appearing as the primary indexed condition, and to 3 interventions - of which Trout is the first listed.

NCT06721468 reports a single indexed study location in Idaho, Washington.

Frequently Asked Questions

What is clinical trial NCT06721468 about?

NCT06721468 is a clinical study titled "Trout Consumption in Young Children and Families and Brain Health". Regular fish consumption may support brain health. Trout lines developed in Idaho contain higher levels of omega-3 fatty acids, nutrients important for human cognition and mental wellbeing. Developed to support aquaculture sustainability, consumer preferences and human health benefits of these fish ...

What is the current status of trial NCT06721468?

This trial is currently recruiting. It is a NA study. The enrollment target is 99 participants. The study started on 2024-05-13. Estimated completion is 2027-12-31.

What conditions does trial NCT06721468 study?

This clinical trial studies the following conditions: Cognitive Change, Well-Being, Psychological.

What interventions are being tested in trial NCT06721468?

The interventions under investigation include: Trout (OTHER), Child-centered nutrition phrases (OTHER), Puzzle (OTHER).

Who is sponsoring clinical trial NCT06721468?

This trial is sponsored by University of Idaho, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06721468 being conducted?

This trial has 2 study locations across Idaho, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Change

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06721468's enrollment target sits among peer trials

99 16th of 44 higher than 29 of 44 other Cognitive Change trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cognitive Change trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03965234 · 99 participants · Phase 1

    Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

  • NCT04022616 · 99 participants

    Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

  • NCT04042844 · 99 participants · Phase 2

    A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)

  • NCT04143724 · 99 participants · Phase 2

    Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06721468, the US trial registry maintained by the National Library of Medicine. NCT06721468 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.